European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.

Automated summary

The aim of this guidance paper is to provide practical guidance for specialists in the diagnosis and management of well-differentiated gastric and duodenal neuroendocrine tumours (NETs) by updating the previous ENETS guidelines. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered in this paper as they will be discussed in other ENETS guidance papers.